Latest news
Ultragenyx Pharmaceutical's (RARE) Buy Rating Reiterated at HC Wainwright - MarketBeatMarketBeat · Mon, 10 Aug 2026 12:23:46 GMTRARE Reiterated by HC Wainwright & Co. -- Rating Maintained at B - GuruFocusGuruFocus · Mon, 10 Aug 2026 10:57:39 GMTSei Investments Co. Sells 61,632 Shares of Ultragenyx Pharmaceutical Inc. $RARE - MarketBeatMarketBeat · Mon, 10 Aug 2026 08:46:59 GMTHow Investors Are Reacting To Ultragenyx Pharmaceutical (RARE) Q2 Revenue Gain And Narrower Net Loss - simplywall.stsimplywall.st · Mon, 10 Aug 2026 08:33:04 GMTIs Q2 Revenue Growth And Narrower Loss Altering The Investment Case For Ultragenyx Pharmaceutical (RARE)? - Yahoo FinanceYahoo Finance · Sun, 09 Aug 2026 22:16:37 GMTHas Ultragenyx Pharmaceutical (RARE) Fallen Far Enough To Avoid Overvaluation? - Yahoo FinanceYahoo Finance · Sun, 09 Aug 2026 03:22:00 GMTUltragenyx Pharmaceutical (RARE) Following Q2 Results Looks Close To Fair Value - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 22:12:37 GMTRARE Stock Slumps On Multiple Wall Street Price Target Slashes, Clinical Pipeline Uncertainty - StocktwitsStocktwits · Sat, 08 Aug 2026 21:39:38 GMT